Meanwhile, to examine whether the onset of diabetes caused by STZ administration affected the expression of M-LP/Mpv17L, we analyzed its expression in the pancreas of the WT-control and the WT-STZ groups at 13 days after STZ treatment. Here, MPV17L is linked to diabetes mellitus.